Reshape Lifesciences Inc is a developer of minimally invasive medical devices to treat obesity and metabolic diseases. The company's current portfolio includes the LAP-BAND, an Adjustable Gastric Banding System, the ReShape Vest, an investigational device, to help treat more patients with obesity, a... Reshape Lifesciences Inc is a developer of minimally invasive medical devices to treat obesity and metabolic diseases. The company's current portfolio includes the LAP-BAND, an Adjustable Gastric Banding System, the ReShape Vest, an investigational device, to help treat more patients with obesity, and ReShapeCare, a virtual coaching program delivered through an app. Show more
Revenue Increased 16.6% in the Third Quarter of 2024 Over the Second Quarter, Representing the Third Sequential Quarter of Growth, and 6.4% Compared to the Same Period in 2023 Significant...
IRVINE, Calif., Nov. 12, 2024 (GLOBE NEWSWIRE) -- ReShape Lifesciences Inc. (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health-solutions company, today announced that it...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.17 | 3.88127853881 | 4.38 | 4.75 | 4.26 | 16239 | 4.43369629 | CS |
4 | -1.19 | -20.7317073171 | 5.74 | 5.94 | 4.09 | 28360 | 4.91341063 | CS |
12 | -0.45 | -9 | 5 | 7.2 | 4.09 | 91921 | 5.61449128 | CS |
26 | -7.05 | -60.775862069 | 11.6 | 16.5996 | 4.09 | 709648 | 10.81878968 | CS |
52 | -11.661 | -71.932638332 | 16.211 | 29 | 4.09 | 1969610 | 13.68303302 | CS |
156 | -5737.45 | -99.9207593173 | 5742 | 5771 | 4.09 | 1513216 | 160.2889766 | CS |
260 | -748.58 | -99.3958546333 | 753.13 | 27550 | 4.09 | 1426149 | 3160.33892205 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.